Circulating IL-23 Levels and Correlation with SLE Disease Activity: A Meta-Analysis
Aktuelle Rheumatologie · 2026-07-01 · 51 (04) · 229-236
DOI: 10.1055/a-2720-5838 ↗Abstract
Abstract This study aimed to evaluate the relationship between circulating interleukin-23 (IL-23) levels and systemic lupus erythematosus (SLE) as well as the correlation between plasma/serum IL-23 levels and SLE activity. The MEDLINE, EMBASE, and Web of Science databases were searched for relevant publications up to February 2025. We performed a meta-analysis comparing plasma/serum IL-23 levels between patients with SLE and healthy controls and examined correlation coefficients between circulating IL-23 levels and SLE disease activity. Sixteen studies comprising 1,125 patients with systemic lupus erythematosus (SLE) and 774 healthy controls were included. Circulating IL-23 levels were significantly elevated in the SLE group compared with controls (standardised mean difference [SMD]=1.225, 95% confidence interval [CI]=10.803–1.647, p70) and small-sample (n
EUVIMED